Lataa...
Hypercalcaemia in osteogenesis imperfecta treated with pamidronate
Accepted 10 September 1996 The response to the bisphophosphonate, pamidronate, is reported in a child with osteogenesis imperfecta who had recurrent symptomatic hypercalcaemia after immobilisation following fractures. Oral clodronate was effective in the prevention of immobilisation hypercalcaemia...
Tallennettuna:
| Päätekijät: | , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BMJ Group
1997
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1717065/ https://ncbi.nlm.nih.gov/pubmed/9068314 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|